With its portfolio of powerful, complementary brands, the Dermatological Beauty Division is unique in creating products that help to treat skin conditions and meet aesthetic demand. Capitalising on cutting-edge innovations in dermocosmetics and the trust-based relationships built with healthcare professionals, the Division continues to provide consumers with the dermatological solutions best suited to their needs.
Share
Innovation, skin health, gratitude to the healthcare professionals and L’Oréal teams behind the Division’s success: Myriam Cohen-Welgryn, President, Dermatological Beauty, unpacks the Division’s outstanding performance in 2023.
Share
We offer life-changing dermatological solutions to all in a sustainable way.
The Dermatological Beauty Division had spectacular growth of +28.4% like-for-like and +25.5% reported.
Dermatological Beauty maintained its outstanding momentum, growing twice as fast as the highly dynamic dermocosmetics market, and delivering its sixth consecutive year of double-digit growth. As a result, sales have more than doubled in just three years.
This was driven by the Division’s unrivalled portfolio of highly complementary brands, its online and offline channel coverage, and its longstanding medical prescription leadership.
Momentum was strong across all regions and well balanced between developed and emerging markets. In mainland China, the Division significantly outperformed a market that proved resilient.
+28.4%growth in Division sales
117scientific posters accepted by the World Congress of Dermatology
290,000professional healthcare partners
3brands in the top four brands dermatologists recommend most worldwide
Highlights
This image will not appear while you are browsing the site in energy-saver mode
This image will not appear while you are browsing the site in energy-saver mode
Shaping the future of dermatological beauty
L’Oréal Dermatological Beauty pursued its remarkable growth thanks to two major assets: its pioneering role in dermocosmetics and a unique model underpinned by medical recommendations.
Expanding the frontiers of science and skin health
The Division leverages L’Oréal’s powerful Research & Innovation to develop revolutionary solutions for the dermocosmetics market. This approach embraces all scientific fields, such as skin ageing and the impact of the exposome (external environmental factors such as the weather, pollution and allergens), the microbiome and glycation. The anti-UV filter Mexoryl 400, which features in the Anthelios UVMune 400 suncare range and has been proven effective at protecting the skin from the most damaging UVA rays, is a standout example. As is the A.G.E. Interrupter Advanced corrective cream by SkinCeuticals, designed to correct the visible signs of ageing due to collagen decline and glycation, such as wrinkles, loss of firmness and radiance.
Innovating to meet changing beauty and health needs
The Division, which sits at the crossroads of beauty and health, creates innovative products that address skin conditions on the one hand and booming aesthetic demand on the other. To treat hyperpigmentation issues related to environmental factors, Vichy launched its Liftactiv B3 Serum, which offers three benefits: it enhances radiance, evens out skin tone, and reduces the visibility of fine lines and wrinkles. La Roche-Posay continued to perfect its formulas with, for example, Cicaplast B5 Repairing Balm, formulated with the prebiotic complex Tribioma which rebalances the skin’s protective microbiome for optimal health. Cicaplast B5 Repairing Balm immediately soothes the skin and creates favourable conditions to restore its protective barrier. Vichy continued to develop the Dercos anti-dandruff range, which became the anti-dandruff brand most recommended by dermatologists worldwide in 2023.
Rolling out powerful brands to boost growth
One in four people suffer from a skin condition and 620 million intend to undertake aesthetic procedures. To meet this significant demand, the Division capitalises on its portfolio of highly complementary brands and its geographical footprint. L’Oréal Dermatological Beauty is the biggest contributor to the Group’s growth thanks to double-digit growth in all Regions. The Division also expanded its presence in new markets in 2023, including India and Nigeria. In 2023, brands once again strengthened their leads, recording double-digit growth. La Roche-Posay, Vichy and CeraVe are now among the brands most prescribed by dermatologists. CeraVe, which has long been the number one dermatological beauty brand in the United States, continued its international rollout with a promising start in the Indian market.
This image will not appear while you are browsing the site in energy-saver mode
This image will not appear while you are browsing the site in energy-saver mode
Making skin health accessible for all
Around the globe, the number of skin conditions is growing — as are waiting times to see a dermatologist due to a global shortage of practitioners. As the leader in dermatological beauty, L’Oréal is committed to improving knowledge, developing education and awareness-raising initiatives, and democratising access to the latest technology-enabled solutions.
Improving knowledge with dermatologists
The Division has continued to strengthen its relationship with more than 290,000 healthcare professionals by involving dermatologists in its clinical studies and developing medical knowledge in skin and hair science through conferences and other events. Healthcare professionals who subscribe also have access to a platform of scientific and educational content. The Division is going a step further with two initiatives designed to alleviate the obstacles in accessing skin health. First, a far-reaching, global study conducted in partnership with Harvard and the International League of Dermatological Societies (ILDS) aims to better understand the hurdles which hinder access to skin health worldwide. Second, the Division has earmarked €2 million to facilitate access to skin health science and research. This will allow dermatologists in lower income countries to access scientific articles and ensure they benefit from free access to their own articles when local studies are published.
Raising consumer awareness about hair and skin health
Each Division brand has its own field of expertise. One way they capitalise on their cutting-edge knowledge is by sharing it with consumers and guiding them to the most suitable products. For example, La Roche-Posay raises consumer awareness about skin cancer with preventive campaigns on detecting melanomas and apps like My Skin Check. Vichy raises awareness on the impact of hormonal changes on the skin and helps women deal with major hormonal shifts such as puberty, pregnancy and menopause. CeraVe also uses social media to educate consumers with campaigns such as #LikeADerm, which features partner dermatologists and influencers to promote healthy habits and adapted products.
Using technology to democratise access
Technology-enabled tools can also help consumers learn more about skin health. QR codes on product packaging provide access to additional information (ingredients, environmental impact, reviews, etc.) and tips for use, including routines and tutorials. Beauty Tech enhances product performance and has expanded access to skin health. Spotscan by La Roche-Posay is an excellent example. The app uses artificial intelligence to provide a personalised diagnosis and routine for acne-prone skin. This is an important first step for consumers looking to gain a better understanding of their skin condition and find suitable solutions. The technology goes beyond aesthetic concerns to tackle a public health issue: acne can have a major impact on self-esteem, with one in four acne sufferers feeling rejected or looked at with disgust.
This image will not appear while you are browsing the site in energy-saver mode
This image will not appear while you are browsing the site in energy-saver mode
Strengthening our lead with healthcare professionals
The World Congress of Dermatology was an opportunity for L’Oréal Dermatological Beauty to confirm its position as the dermocosmetic leader and strengthen its ties with 9,000 healthcare professionals from 150 countries. With a stand spanning more than 600 square metres, four brand symposiums and 117 scientific posters, the Division showcased the Group’s latest innovations and scientific expertise. The Congress included four Division studies in the “Breaking News” category, including two epidemiological studies: one by La Roche-Posay about the frequency of pigmentation issues and their impact on quality of life, and the other by Vichy about the impact of hormonal variations on the hair and skin. The other two studies highlighted the scientifically proven role dermocosmetics play in treating skin conditions, alone or in combination with prescription drugs.
This image will not appear while you are browsing the site in energy-saver mode
This image will not appear while you are browsing the site in energy-saver mode
Brands committed to public health and prevention
L’Oréal Dermatological Beauty’s unique relationship with healthcare professionals has made the Division’s brands influential players in public health and prevention – a position they use to raise awareness and change consumer habits. L’Oréal develops new strategies to reach a wide audience and raise awareness about major issues such as the risks of skin ageing from sun exposure and the importance of UV protection. In Brazil, for instance, La Roche-Posay has launched an innovative new app which uses before-and-after photos to highlight accelerated ageing due to excessive UV exposure. The initiative has been a major success with consumers, who now have a better understanding of the importance of UV protection, and healthcare professionals, who have helped promote this new awareness-raising tool.
This image will not appear while you are browsing the site in energy-saver mode
This image will not appear while you are browsing the site in energy-saver mode
International award for responsible dermatology
In partnership with the International League of Dermatological Societies (ILDS), L’Oréal presented its international awards for social responsibility in dermatology at the World Congress of Dermatology. In line with the Division’s mission to improve access to skin health for all, the awards recognise the dermatologists behind impactful projects designed to promote prevention and education, improve quality of life and self-esteem for people with skin conditions, and facilitate access to treatment and surgery.
One notable winner was Dr Wendemagegn Enbiale Yeshaneh, whose NaPAN project has improved access to services for patients with tropical skin diseases in Ethiopia. He will receive a grant to help fund treatment for patients with severe nodules caused by these diseases, support training for professionals in areas where such issues are endemic and promote research into new treatments.
